ALDOSTERONE RENIN DIRECT RATIO PLASMA Test
Test Name: ALDOSTERONE RENIN DIRECT RATIO PLASMA Test
Components: 3 mL (2.5 mL min.) plasma from 1 LavenderTop(EDTA)tube
Price: 1570.0 AED
Sample Condition: Patient should be ambulatory / upright 2 hours prior to the test. Separate plasma and freeze. Ship frozen. DO NOT THAW.
Drug Interactions: Potassium wasting diuretics, Spironolactone, Eplerenone, Amiloride and Triamterene should be discontinued at least for 4 weeks; Adrenergic blockers, Clonidine, Methyldopa, NSAIDs, Angiotensin-converting enzyme inhibitors, Angiotensin receptor blockers, Renin inhibitors and Dihydropyridine calcium channel antagonists should be discontinued for 2 weeks. If necessary to maintain hypertension control, patients should be treated with other antihypertensive medications like Verapamil slow-release, Hydralazine, Prazosin, Doxazosin & Terazosin that have lesser effects on Plasma renin & aldosterone levels. Any change in medication should be done in consultation with treating physician.
Report Delivery: Sample Tue / Fri by 11 am; Report Same day
Method: CLIA
Test Type: Disorders of Adrenal Gland
Doctor: Endocrinologist
Test Department:
Pre Test Information: Patient should be ambulatory / upright 2 hours prior to sampling. Drug interactions to be noted: Potassium wasting diuretics, Spironolactone, Eplerenone, Amiloride and Triamterene should be discontinued at least for 4 weeks; Adrenergic blockers, Clonidine, Methyldopa, NSAIDs, Angiotensin-converting enzyme inhibitors, Angiotensin receptor blockers, Renin inhibitors and Dihydropyridine calcium channel antagonists should be discontinued for 2 weeks. If necessary to maintain hypertension control, patients should be treated with other antihypertensive medications like Verapamil slow-release, Hydralazine, Prazosin, Doxazosin & Terazosin that have lesser effects on Plasma renin & aldosterone levels. Any change in medication should be done in consultation with treating physician.
Test Details:
The aldosterone/renin direct ratio plasma test is a blood test that measures the levels of aldosterone and renin in the blood to assess the functioning of the renin-angiotensin-aldosterone system (RAAS). Aldosterone is a hormone produced by the adrenal glands that helps regulate blood pressure and electrolyte balance in the body. Renin is an enzyme produced by the kidneys that plays a key role in the RAAS, which helps regulate blood pressure and fluid balance.
The aldosterone/renin direct ratio is calculated by dividing the level of aldosterone by the level of renin in the blood. This ratio provides information about the activity of the RAAS and can help diagnose and monitor conditions such as primary aldosteronism (a disorder characterized by excessive aldosterone production) and secondary hypertension (high blood pressure caused by an underlying condition). A high aldosterone/renin ratio may indicate primary aldosteronism, while a low ratio may suggest secondary hypertension or other conditions affecting the RAAS.
The test is typically ordered if a healthcare provider suspects an issue with the RAAS or wants to evaluate the effectiveness of treatment for conditions such as primary aldosteronism. It is important to note that the aldosterone/renin direct ratio plasma test is just one tool used in diagnosing and managing conditions related to the RAAS. Other tests and clinical evaluations may be necessary to confirm a diagnosis and determine the appropriate treatment plan.
| Test Name | ALDOSTERONE RENIN DIRECT RATIO PLASMA Test |
|---|---|
| Components | |
| Price | 1570.0 AED |
| Sample Condition | 3 mL (2.5 mL min.) plasma from 1 LavenderTop(EDTA)tube. Patient should be ambulatory \/ upright 2 hours prior to the test. Separate plasma and freeze. Ship frozen. DO NOT THAW. Drug interactions to be noted: Potassium wasting diuretics, Spironolactone, Eplerenone, Amiloride and Triamterene should be discontinued at least for 4 weeks;Adrenergic blockers, Clonidine, Methyldopa, NSAIDs, Angiotensin-converting enzyme inhibitors, Angiotensin receptor blockers, Renin inhibitors and Dihydropyridine calcium channel antagonists should be discontinued for 2 weeks. If necessary to maintain hypertension control, patients should be treated with other antihypertensive medications like Verapamil slow-release, Hydralazine, Prazosin, Doxazosin & Terazosin that have lesser effects on Plasma renin & aldosterone levels. Any change in medication should be done in consultation with treating physician. |
| Report Delivery | Sample Tue / Fri by 11 am; Report Same day |
| Method | CLIA |
| Test type | Disorders of Adrenal Gland |
| Doctor | Endocrinologist |
| Test Department: | |
| Pre Test Information | Patient should be ambulatory / upright 2 hours prior to sampling. Drug interactions to be noted: Potassium wasting diuretics, Spironolactone, Eplerenone, Amiloride and Triamterene should be discontinued at least for 4 weeks;Adrenergic blockers, Clonidine, Methyldopa, NSAIDs, Angiotensin-converting enzyme inhibitors, Angiotensin receptor blockers, Renin inhibitors and Dihydropyridine calcium channel antagonists should be discontinued for 2 weeks. If necessary to maintain hypertension control, patients should be treated with other antihypertensive medications like Verapamil slow-release, Hydralazine, Prazosin, Doxazosin & Terazosin that have lesser effects on Plasma renin & aldosterone levels. Any change in medication should be done in consultation with treating physician. |
| Test Details |
The aldosterone/renin direct ratio plasma test is a blood test that measures the levels of aldosterone and renin in the blood to assess the functioning of the renin-angiotensin-aldosterone system (RAAS). Aldosterone is a hormone produced by the adrenal glands that helps regulate blood pressure and electrolyte balance in the body. Renin is an enzyme produced by the kidneys that plays a key role in the RAAS, which helps regulate blood pressure and fluid balance. The aldosterone/renin direct ratio is calculated by dividing the level of aldosterone by the level of renin in the blood. This ratio provides information about the activity of the RAAS and can help diagnose and monitor conditions such as primary aldosteronism (a disorder characterized by excessive aldosterone production) and secondary hypertension (high blood pressure caused by an underlying condition). A high aldosterone/renin ratio may indicate primary aldosteronism, while a low ratio may suggest secondary hypertension or other conditions affecting the RAAS. The test is typically ordered if a healthcare provider suspects an issue with the RAAS or wants to evaluate the effectiveness of treatment for conditions such as primary aldosteronism. It is important to note that the aldosterone/renin direct ratio plasma test is just one tool used in diagnosing and managing conditions related to the RAAS. Other tests and clinical evaluations may be necessary to confirm a diagnosis and determine the appropriate treatment plan. |
